HIMS Stock Forecast & Price Target

Hims & Hers Health is experiencing significant growth, with a reported 55% year-over-year increase in members utilizing personalized products, now constituting approximately 65% of its total membership. The company is expected to expand its international revenue from around $50 million in FY25 to nearly $1 billion by FY30, driven by an increased range of treatments, entry into new markets, and enhancements to customer experience and personalization. Additionally, core US revenue is projected to grow by approximately 21% annually, largely fueled by increases in subscriber numbers and higher revenue per subscriber, highlighting the ongoing expansion of its total addressable market (TAM).

Hims & Hers Health has experienced a downturn of over 20% since late July, despite having more than doubled its share price year-to-date, indicating concerns around slowing core growth. Key issues impacting future performance include the potential for slower adoption of personalized treatments, regulatory challenges in the healthcare industry, and heightened competition in the digital health space. Additionally, the company's reliance on consumer disposable income for its direct-to-consumer subscriptions poses a risk if economic conditions deteriorate.